Prohibitin confers cytoprotection against ISO-induced hypertrophy in H9c2 cells via attenuation of oxidative stress and modulation of Akt/Gsk-3β signaling

Molecular and Cellular Biochemistry

Volumn 425, Issue 1-2, 2017, Pages 155-168

  Chowdhury, Debabrata ^a   Kumar, Dinesh ^a   Bhadra, Utpal ^b   Devi, Tangutur Anjana ^a   Bhadra, Manika Pal ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Akt; Gsk 3 ; Hypertrophy; Isoproterenol; Oxidative stress; Prohibitin

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; ISOPRENALINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROHIBITIN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SUPEROXIDE; GSK3B PROTEIN, RAT; REPRESSOR PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CELL PROTECTION; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE EXPRESSION; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IN VITRO GENE TRANSFER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; HYPERTROPHY; METABOLISM; PATHOLOGY;

ANIMALS; CYTOPROTECTION; GLYCOGEN SYNTHASE KINASE 3 BETA; HYPERTROPHY; ISOPROTERENOL; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 84995528351     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-016-2870-3     Document Type: Article

References (33)

1. Berenji K, Drazner MH, Rothermel BA, Hill JA (2005) Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol 289(1):H8–H16
2. Zhang W, Elimban V, Nijjar MS, Gupta SK, Dhalla NS (2003) Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure. Exp Clin Cardiol 8(4):173–183
3. Konishi H, Tanaka M, Takemura Y, Matsuzaki H, Ono Y, Kikkawa U, Nishizuka Y (1997) Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci USA 94(21):11233–11237
4. Ushio-Fukai M, Alexander WR, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK (1999) Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 274(32):22699–22704
5. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3β by insulin mediated by protein kinase B. Nature 378(6559):785–789
6. Morisco C, Zebrowski D, Condorelli G, Tsichlis P, Vatner SF, Sadoshima J (2000) The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes. J Biol Chem 275(19):14466–14475
7. Antos CL, McKinsey TA, Frey N, Kutschke W, McAnally J, Shelton JM, Richardson JA, Hill JA, Olson EN (2002) Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 99(2):907–912
8. Morisco C, Seta K, Hardt SE, Lee Y, Vatner SF, Sadoshima J (2001) Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J Biol Chem 276(30):28586–28597
9. Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A, Molkentin JD, Alessandrini A, Woodgett J, Hajjar R, Michael A, Force T (2000) Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 151(1):117–130
10. Badorff C, Ruetten H, Mueller S, Stahmer M, Gehring D, Jung F, Ihling C, Zeiher AM, Dimmeler S (2002) Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. J Clin Invest 109(3):373–381
11. Thompson WE, Powell JM, Whittaker JA, Sridaran R, Thomas KH (1999) Immunolocalization and expression of prohibitin, a mitochondrial associated protein within the rat ovaries. Anat Rec 256(1):40–48
12. Thompson WE, Ramalho-Santos J, Sutovsky P (2003) Ubiquitination of prohibitin in mammalian sperm mitochondria: possible roles in the regulation of mitochondrial inheritance and sperm quality control. Biol Reprod 69(1):254–260
13. Yurugi H, Rajalingam K (2013) A role for prohibitin in mast cell activation: location matters. Sci Signal 6(292):pe29
14. Li QF, Liang Y, Shi SL, Liu QR, Xu DH, Jing GJ, Wang SY, Kong HY (2011) Localization of prohibitin in the nuclear matrix and alteration of its expression during differentiation of human neuroblastoma SK-N-SH Cells induced by retinoic acid. Cell Mol Neurobiol 31:203–211
15. Chowdhury D, Tangutur AD, Khatua TN, Saxena P, Banerjee SK, Bhadra MP (2013) A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats. J Transl Med 11:130
16. Zheng H, Lu GM (2015) Reduction of prohibitin expression contributes to left ventricular hypertrophy via enhancement of mitochondrial reactive oxygen species formation in spontaneous hypertensive rats. Free Radic Res 49(2):164–174
17. Watkins SJ, Borthwick GM, Arthur HM (2011) The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. Vitro Cell Dev Biol Anim 47(2):125–131
18. Molojavyi A, Lindecke A, Raupach A, Moellendorf S, Köhrer K, Gödecke A (2010) Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy. Physiol Genom 41(2):137–145
19. Halliwell B (1991) Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 91(3C):14S–22S
20. Dorn GW 2nd, Force T (2005) Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115(3):527–537
21. Oudit GY, Penninger JM (2009) Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc Res 82(2):250–260
22. Tang Q, Cai J, Shen D, Bian Z, Yan L, Wang YX, Lan J, Zhuang GQ, Ma WZ, Wang W (2009) Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling. J Mol Med (Berl) 87(3):249–260
23. Prathapan A, Vineetha VP, Raghu KG (2014) Protective effect of Boerhaavia diffusa L. against mitochondrial dysfunction in angiotensin II induced hypertrophy in H9c2 cardiomyoblast cells. PLoS ONE 9(4):e96220
24. Martelli AM, Evangelisti C, Chappell W, Abrams SL, Bäsecke J, Stivala F, Donia M, Fagone P, Nicoletti F, Libra M, Ruvolo V, Ruvolo P, Kempf CR, Steelman LS, McCubrey JA (2011) Targeting the translational apparatus to improve leukemia therapy: roles of the PI3 K/PTEN/Akt/mTOR pathway. Leukemia 25(7):1064–1079
25. Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, Yang Q, Bennett C, Harada Y, Stankunas K, Wang CY, He X, MacDougald OA, You M, Williams BO, Guan KL (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3β to regulate cell growth. Cell 126(5):955–968
26. Schleicher M, Shepherd BR, Suarez Y, Fernandez-Hernando C, Yu J, Pan Y, Acevedo LM, Shadel GS, Sessa WC (2008) Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol 180(1):101–112
27. Dhalla AK, Hill MF, Singal PK (1996) Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 28(2):506–514
28. Date MO, Morita T, Yamashita N, Nishida K, Yamaguchi O, Higuchi Y, Hirotani S, Matsumura Y, Hori M, Tada M, Otsu K (2002) The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol 39(5):907–912
29. Byrne JA, Grieve DJ, Bendall JK, Li JM, Gove C, Lambeth JD, Cave AC, Shah AM (2003) Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 93(9):802–805
30. Jiang L, Dong P, Zhang Z, Li C, Li Y, Liao Y, Li X, Wu Z, Guo S, Mai S, Xie D, Liu Z, Zhou F (2015) Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells. Cell Death Dis 6:e1660
31. Bavelloni A, Piazzi M, Faenza I, Raffini M, D’Angelo A, Cattini L, Cocco L, Blalock WL (2014) Prohibitin 2 represents a novel nuclear AKT substrate during all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. FASEB J 28:2009–2019
32. Chowdhury I, Thompson WE, Thomas K (2014) Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway. J Cell Physiol 229:998–1004
33. Chiu CF, Ho MY, Peng JM, Liang SM (2013) Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane. Oncogene 32:777–787